Search
111 Inc
YIAdd to Watchlist
6.000USD
-0.100-1.64%
Close 05/14, 16:00（ET）Quotes delayed by 15 min
52.78MMarket Cap
LossP/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.64%
5 Days
+7.53%
1 Month
-11.89%
6 Months
+47.10%
Year to Date
+134.38%
1 Year
-21.16%
TradingKey Stock Score of 111 Inc
Currency: USD Updated: 2026-05-14Key Insights
111 Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 123 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
111 Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
111 Inc Highlights
StrengthsRisks
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Undervalued
The company’s latest PE is -54.99, at a low 3-year percentile range.
Held by James Simons
Star Investor James Simons holds 12.71K shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
111 Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
111 Inc Info
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Ticker SymbolYI
Company111 Inc
CEOLiu (Junling)
Websitehttp://corporate.111.com.cn/
Related Instruments
-0.89%
+0.16%
+1.09%
+0.01%
-1.47%
-0.04%
-0.07%
-0.74%
-2.72%
-0.81%
+0.67%
-0.58%
+1.01%
-0.06%
+1.36%
-0.97%
0.00%
-0.06%
+2.42%
+4.31%Popular Instruments
101.110
+2.247 (+2.27%)
298.210
-0.660 (-0.22%)
235.740
+9.910 (+4.39%)
4548.360
-101.870 (-2.19%)
489.150
-4.940 (-1.00%)
1382.720
-64.510 (-4.46%)
776.010
-27.620 (-3.44%)
401.070
-1.550 (-0.38%)
80560.000
-822.040 (-1.01%)
443.300
-1.970 (-0.44%)
